
NeuroReality
NeuroReality aims to change the way people approach cognitive training and rehabilitation.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
* | N/A | Acquisition | |
Total Funding | 000k |

USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | - | 8 % |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
NeuroReality is a digital health company specializing in virtual reality (VR) solutions for cognitive rehabilitation. Founded in 2017 by Faviola Dadis and headquartered in Amsterdam, the company was established to address the gap in accessible and engaging cognitive therapy. Faviola Dadis's interest in this field was sparked during her Master's research, where she repeatedly encountered individuals suffering from cognitive deficits after a stroke. This led to the idea of creating a gamified VR program to leverage neuroplasticity for recovery. The company was notably acquired by the US-based therapeutic XR platform, XRHealth, in November 2024, a move that integrated NeuroReality's cognitive tools into XRHealth's broader digital health ecosystem.
The company's core business revolves around developing and providing VR-based software for patients with acquired brain injuries, such as those from a stroke or severe concussion, as well as individuals with neurodegenerative conditions or those interested in healthy aging. Its business model targets both clinical settings, like rehabilitation centers, and individual patients for at-home use. For clinicians, NeuroReality offers a backend platform to create personalized training plans, monitor patient performance, and track progress over time, enabling remote tele-rehabilitation. This resource-friendly approach allows for independent or group sessions, freeing up clinician time. The company has received funding from institutional investors, including DutchBasecamp and Rising Stars Ventures.
NeuroReality's flagship product is Koji's Quest, a CE-marked Class I medical device. This VR-based serious game combines neuroscientific principles with gamification to train a wide range of cognitive skills, including memory, attention, executive functions, and reaction time. Koji's Quest immerses users in various virtual environments where they perform tasks that adapt in difficulty using smart algorithms, ensuring the training remains challenging but not overwhelming. Key features include a virtual companion named Koji who offers encouragement, a reward system to boost motivation, and relaxation areas for breaks. The software is designed with six degrees of freedom (6DOF) to enhance realism and skill transfer to daily life and is available in multiple languages, making it accessible to a global audience.
Keywords: cognitive rehabilitation, virtual reality therapy, neuro-rehabilitation, brain training, Koji's Quest, stroke recovery, traumatic brain injury, digital therapeutics, gamification in healthcare, tele-rehabilitation, neuroplasticity, acquired brain injury, XRHealth, Faviola Dadis, cognitive skills training, remote patient monitoring, serious games for health, medical VR, Amsterdam MedTech, cognitive assessment